US EditionAnalysis of SAVVE Pivotal Trial Data Presented for enVVeno VenoValve - Endovascular Today
Summary by Endovascular Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Analysis of SAVVE Pivotal Trial Data Presented for enVVeno VenoValve - Endovascular Today
April 15, 2025—enVVeno Medical Corporation recently announced the presentation of findings from a subanalysis of the 1-year data from the prospective, multicenter SAVVE pivotal trial of the company’s VenoValve, a bioprosthetic replacement venous valve surgically implanted into the femoral vein being developed for treatment of severe chronic venous insufficiency (CVI) in the deep veins of the legs. Cassius Iyad Ochoa Chaar, MD, presented the anal…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
